A UNLV-led team of researchers has co-opted a common kitchen spice to create a new class of cannabidiol (CBD)-like medicines that show powerful seizure-reducing effects – offering a safer, more affordable, and more effective treatment for childhood seizure disorders than existing frontline therapies.